Fighting for victims of Medtronic Sprint Fidelis Leads
Email this page to a friend Print this page

WWW.FINZFIRM.COM
1-888-FINZFIRM
1-888-346-9347
Finz & Finz, P.C.
Attorneys And Counselors At Law

Medtronic approved to sell heart lead in Japan

Dec 18, 2007 | Associated Press | Guardian Unlimited

Medtronic Inc on Monday said it received approval from regulators in Japan to sell its Sprint Quattro lead used with implantable cardioverter-defibrillators (ICDs) that detect and treat rapid heart rhythms. The medical device maker said it hopes to receive reimbursement approval for the product by Jan. 1, which would allow for its immediate commercial launch in Japan, a key market. The product has been in use in Europe and the United States since 2001. Medtronic in October suspended all sales of the Sprint Fidelis line of leads, or wires that link the heart to an ICD, upon finding the equipment may have contributed to five patient deaths. (Reporting by Susan Kelly, editing by Gerald E. McCormick)


(required) Denotes required field


Title


(required) First Name


(required) Last Name


(required) Phone Number


Email Address


Address


City


(required) State


Zip Code


Best Way/Time to Contact You


Injured Person's Name


Injured Person's Date of Birth
(mm/dd/yyyy)

Date of Incident
(mm/dd/yyyy)

Type of Incident


Please Describe the Incident


Please sign me up for the Finz & Finz, P.C. Newsletter


I agree to the Finz & Finz, P.C. Terms of Use